SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Abrams, S.M.L.
Right arrow Articles by Turner, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Abrams, S.M.L.
Right arrow Articles by Turner, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pharmacokinetic Interaction Between Indoramin and Ethanol

S.M.L. Abrams

Department of Clinical Pharmacology, St Bartholomew's Hospital, London, EC1A 7BE

D.M. Pierce

Drug Metabolism and Pharmacokinetics Section, Wyeth Research (UK) Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berks, SL6 OPH, UK

A. Johnston

Department of Clinical Pharmacology, St Bartholomew's Hospital, London, EC1A 7BE

A. Hedges

Department of Clinical Pharmacology, St Bartholomew's Hospital, London, EC1A 7BE

R.A. Franklin

Drug Metabolism and Pharmacokinetics Section, Wyeth Research (UK) Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berks, SL6 OPH, UK

P. Turner

Department of Clinical Pharmacology, St Bartholomew's Hospital, London, EC1A 7BE

1 The effect of ethanol consumption (0.5 g/kg) on the pharmacokinetics of the alpha adrenoceptor antagonist indoramin, administered orally (50 mg) or intravenously (0.175 mg/kg) has been investigated in young volunteers. Sedation was also assessed using a visual analogue scale.

2 After oral indoramin administration, ethanol caused increases of 58% (P <0.01) in CPmax , and 25% (P <0.05) in AUC. There was no effect of alcohol on elimination half-life. The combination of ethanol and indoramin was more sedative than indoramin alone.

3 Ethanol did not alter the pharmacokinetics of an intravenous dose of indoramin. However indoramin caused a small but statistically significant increase (26%) in blood ethanol concentrations during the first 1.25 h after dosing. Both indoramin and ethanol caused sedation.

4 The increased bioavailability of oral indoramin in the presence of ethanol may reflect some enhanced absorption, but it is also consistent with inhibition of first-pass metabolism of a flow-limited drug. The clinical implications are discussed.

Human & Experimental Toxicology, Vol. 8, No. 3, 237-241 (1989)
DOI: 10.1177/096032718900800306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement